SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Alexander L. Fogel, Sharleen Hill, Joyce M.C. Teng, Advances in the therapeutic use of mammalian target of rapamycin (mTOR) inhibitors in dermatology, Journal of the American Academy of Dermatology, 2015, 72, 5, 879

    CrossRef

  2. 2
    R. Balestri, I. Neri, A. Patrizi, L. Angileri, L. Ricci, M. Magnano, Analysis of current data on the use of topical rapamycin in the treatment of facial angiofibromas in Tuberous Sclerosis Complex, Journal of the European Academy of Dermatology and Venereology, 2015, 29, 1
  3. 3
    Kai-Che Wei, Ping-Chin Lai, Combination of everolimus and tacrolimus: a potentially effective regimen for recalcitrant psoriasis, Dermatologic Therapy, 2015, 28, 1
  4. 4
    Emma V. Pynn, Jemma Collins, Prasad R. Y. Hunasehally, Jenny Hughes, Successful Topical Rapamycin Treatment for Facial Angiofibromata in Two Children, Pediatric Dermatology, 2015, 32, 3
  5. 5
    Stephanie K. Jacks, Patricia M. Witman, Tuberous Sclerosis Complex: An Update for Dermatologists, Pediatric Dermatology, 2015, 32, 3
  6. 6
    Sharon Samueli, Klaus Abraham, Anastasia Dressler, Gudrun Groeppel, Constanze Jonak, Angelika Muehlebner, Daniela Prayer, Andreas Reitner, Martha Feucht, Tuberous Sclerosis Complex: new criteria for diagnostic work-up and management, Wiener klinische Wochenschrift, 2015,

    CrossRef

  7. 7
    Paolo Fioramonti, Liliana De Santo, Martina Ruggieri, Sara Carella, Lo Torto Federico, Maria Giuseppina Onesti, Nicolò Scuderi, Co2/Erbium:YAG/Dye Laser Combination: An Effective and Successful Treatment for Angiofibromas in Tuberous Sclerosis, Aesthetic Plastic Surgery, 2014, 38, 1, 192

    CrossRef

  8. 8
    R. Salido-Vallejo, G. Garnacho-Saucedo, J.C. Moreno-Giménez, Current Options for the Treatment of Facial Angiofibromas, Actas Dermo-Sifiliográficas (English Edition), 2014, 105, 6, 558

    CrossRef

  9. 9
    Guang Yang, Lu Yang, Xiaofan Yang, Xiuyu Shi, Jing Wang, Yujie Liu, Jun Ju, Liping Zou, Efficacy and safety of a mammalian target of rapamycin inhibitor in pediatric patients with tuberous sclerosis complex: A systematic review and meta-analysis, Experimental and Therapeutic Medicine, 2014,

    CrossRef

  10. 10
    Deshan F Sebaratnam, Adrian C Lim, Patricia M Lowe, Greg J Goodman, Philip Bekhor, Shawn Richards, Lasers and laser-like devices: Part two, Australasian Journal of Dermatology, 2014, 55, 1
  11. 11
    John A. Lawson, Chi-Fung Chan, Ching-Shiang Chi, Pi-Chuan Fan, Heung Dong Kim, Ki Joong Kim, Surachai Likasitwatanakul, Marilyn Ortiz, Kate Riney, Stacey Kiat-Hong Tay, Chee-Kian Tham, Managing tuberous sclerosis in the Asia-Pacific region: Refining practice and the role of targeted therapy, Journal of Clinical Neuroscience, 2014, 21, 7, 1180

    CrossRef

  12. 12
    Gang Ma, Pinru Wu, Xiaoxi Lin, Hui Chen, Wei Li, Xiaojie Hu, Yunbo Jin, Nd:YAG laser for “fractional” treatment of angiofibromas, International Journal of Dermatology, 2014, 53, 5
  13. 13
    R. Salido-Vallejo, G. Garnacho-Saucedo, J.C. Moreno-Giménez, Opciones terapéuticas actuales para los angiofibromas faciales, Actas Dermo-Sifiliográficas, 2014, 105, 6, 558

    CrossRef

  14. 14
    N. Knöpfel, A. Martín-Santiago, A. Bauza, J.A. Hervás, Rapamicina tópica al 0,2% para el tratamiento de angiofibromas faciales y máculas hipomelanóticas en la esclerosis tuberosa, Actas Dermo-Sifiliográficas, 2014, 105, 8, 802

    CrossRef

  15. 15
    N. Knöpfel, A. Martín-Santiago, A. Bauza, J.A. Hervás, Topical 0.2% Rapamycin to Treat Facial Angiofibromas and Hypomelanotic Macules in Tuberous Sclerosis, Actas Dermo-Sifiliográficas (English Edition), 2014, 105, 8, 802

    CrossRef

  16. 16
    Patricia E. Dill, Gaston De Bernardis, Peter Weber, Uli Lösch, Topical Everolimus for Facial Angiofibromas in the Tuberous Sclerosis Complex. A First Case Report, Pediatric Neurology, 2014, 51, 1, 109

    CrossRef

  17. You have free access to this content17
    Jenny Tu, Rachael S Foster, Lewis J Bint, Anne R Halbert, Topical rapamycin for angiofibromas in paediatric patients with tuberous sclerosis: Follow up of a pilot study and promising future directions, Australasian Journal of Dermatology, 2014, 55, 1
  18. 18
    G. Biondo, S. Greco, L. Mavilia, S. R. Mercuri, Treatment of nodular facial angiofibromas in tuberous sclerosis, using ultrapulse carbon dioxide laser, Clinical and Experimental Dermatology, 2014, 39, 6
  19. 19
    J.S. Wee, H. Chong, J. Natkunarajah, P.S. Mortimer, Y. Moosa, Familial multiple discoid fibromas: unique histological features and therapeutic response to topical rapamycin, British Journal of Dermatology, 2013, 169, 1
  20. You have free access to this content20
    M. Tanaka, M. Wataya-Kaneda, A. Nakamura, S. Matsumoto, I. Katayama, First left–right comparative study of topical rapamycin vs. vehicle for facial angiofibromas in patients with tuberous sclerosis complex, British Journal of Dermatology, 2013, 169, 6
  21. 21
    Darcy A. Krueger, Management of CNS-related Disease Manifestations in Patients With Tuberous Sclerosis Complex, Current Treatment Options in Neurology, 2013, 15, 5, 618

    CrossRef

  22. 22
    Gareth S. Baynam, Mark Walters, Hugh Dawkins, Matthew Bellgard, Anne R. Halbert, Peter Claes, Objective Monitoring of mTOR Inhibitor Therapy by Three-Dimensional Facial Analysis, Twin Research and Human Genetics, 2013, 16, 04, 840

    CrossRef

  23. 23
    Arin Bhattacharya, Rahul Mishra, Prashant Tiwari, Multiple sclerosis: an overview, Asian Pacific Journal of Tropical Biomedicine, 2012, 2, 3, S1954

    CrossRef

  24. 24
    Mary Kay Koenig, Adelaide A. Hebert, Joan Roberson, Joshua Samuels, John Slopis, Audrey Woerner, Hope Northrup, Topical Rapamycin Therapy to Alleviate the Cutaneous Manifestations of Tuberous Sclerosis Complex, Drugs in R&D, 2012, 12, 3, 121

    CrossRef

  25. 25
    Mary Kay Koenig, Adelaide A. Hebert, Joan Roberson, Joshua Samuels, John Slopis, Audrey Woerner, Hope Northrup, Topical Rapamycin Therapy to Alleviate the Cutaneous Manifestations of Tuberous Sclerosis Complex, Drugs in R&D, 2012, 12, 3, 121

    CrossRef

  26. 26
    Teguh H Sasongko, Nur Farrah Dila Ismail, Nik Mohd. Ariff Nik Abdul Malik, Zabidi Azhar Mohd. Hussin, Rapamycin and its analogues (rapalogs) for tuberous sclerosis complex, The Cochrane Library,